Understanding the Evolving Role of Biosimilars in Gastroenterology

Host: Jennifer Caudle, DO <br> Guest: Stephen Hanauer, MD <br> <p>Even though biosimilars serve as a much-needed treatment option for patients in several fields of medicine, gastroenterologists have been reluctant to adopt them. Joining Dr. Jennifer Caudle to explore why this might be and the evolving role of biosimilars in anti-inflammatory care for GI patients is Dr. Stephen Hanauer, Professor of Medicine at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. </p> <p style="text-align: right;"> USA-CBU-81030</p>